Shares of Rocket Lab Corporation (NASDAQ:RKLB – Get Free Report) dropped 4.2% during trading on Wednesday. The company traded as low as $70.63 and last traded at $71.92. 20,373,747 shares traded hands during mid-day trading, a decline of 12% from the average daily volume of 23,069,465 shares. The stock had previously closed at $75.06.
Key Headlines Impacting Rocket Lab
Here are the key news stories impacting Rocket Lab this week:
- Positive Sentiment: Barclays initiated coverage with an Overweight rating and an $85 price target, citing a bullish outlook for the aerospace and defense sector. The target implies meaningful upside from recent levels. Rocket Lab Stock Eyes Rebound After Bullish Coverage
- Positive Sentiment: Rocket Lab’s Neutron rocket could benefit from NASA’s planned bulk launch procurement tied to a potential $30 billion lunar-base program. Recurring government missions would improve the long-term revenue outlook, although Neutron has not yet flown. Rocket Lab Gets a Fresh Opening in NASA’s Moon Push
- Positive Sentiment: Commentary from ARK Invest characterized Neutron as potentially approaching Falcon 9’s capabilities. Analysts also see an opportunity for Rocket Lab if SpaceX’s Starlink and future StarMind deployments create additional demand for launch services. RKLB Rises Overnight: Cathie Wood’s ARK Puts Neutron Close to Falcon 9
- Neutral Sentiment: The proposed Iridium transaction could materially expand Rocket Lab’s earnings base, with Iridium contributing roughly $500 million in annual EBITDA. However, the deal may involve as many as 72 million new shares, creating potential dilution for existing investors. Rocket Lab: Iridium Could Explode EBITDA
- Negative Sentiment: SpaceX’s agreement to secure low-band spectrum is pressuring satellite and space stocks, while renewed attention on SpaceX highlights Rocket Lab’s competitive disadvantage in launch scale and execution. AST SpaceMobile Falls as SpaceX Spectrum Deal Closes Off Low-Band Option
- Negative Sentiment: Recent selling reflects concerns about prior earnings misses, ongoing losses, valuation, and dilution. Jim Cramer also favored SpaceX over Rocket Lab, adding to negative sentiment around RKLB. Jim Cramer Draws a Line Between Rocket Lab and SpaceX
Analyst Ratings Changes
RKLB has been the topic of several recent research reports. KeyCorp restated an “overweight” rating on shares of Rocket Lab in a report on Tuesday, August 11th. Morgan Stanley reaffirmed an “overweight” rating on shares of Rocket Lab in a report on Wednesday, July 8th. KGI Securities upgraded Rocket Lab from a “neutral” rating to an “outperform” rating and set a $107.00 price objective on the stock in a research report on Monday, July 27th. Citigroup assumed coverage on Rocket Lab in a research note on Thursday, October 1st. They set a “buy” rating and a $105.00 price objective on the stock. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Rocket Lab in a report on Friday, July 17th. Four research analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $104.71.
Rocket Lab Price Performance
The company has a debt-to-equity ratio of 0.01, a quick ratio of 4.98 and a current ratio of 5.48. The stock has a market cap of $41.32 billion, a PE ratio of -254.87 and a beta of 2.93. The stock’s 50-day moving average is $70.45 and its two-hundred day moving average is $84.44.
Rocket Lab (NASDAQ:RKLB – Get Free Report) last announced its earnings results on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.02). Rocket Lab had a negative net margin of 21.51% and a negative return on equity of 6.48%. The firm had revenue of $234.07 million during the quarter, compared to analysts’ expectations of $231.62 million. On average, equities analysts predict that Rocket Lab Corporation will post -0.2 earnings per share for the current year.
Insider Transactions at Rocket Lab
In related news, insider Marvin Clevenger sold 15,051 shares of the stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $69.63, for a total transaction of $1,048,001.13. Following the transaction, the insider owned 458,924 shares of the company’s stock, valued at approximately $31,954,878.12. This represents a 3.18% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, SVP Arjun Kampani sold 6,034 shares of the firm’s stock in a transaction dated Thursday, August 27th. The shares were sold at an average price of $66.65, for a total value of $402,166.10. Following the transaction, the senior vice president owned 250,917 shares of the company’s stock, valued at $16,723,618.05. This trade represents a 2.35% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 400,749 shares of company stock worth $26,964,474. 8.40% of the stock is owned by corporate insiders.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently made changes to their positions in the business. Highland Investment Advisors LLC acquired a new stake in Rocket Lab during the 2nd quarter worth approximately $30,000. Meeder Asset Management Inc. purchased a new stake in shares of Rocket Lab during the second quarter worth $30,000. NBH Bank purchased a new stake in shares of Rocket Lab during the second quarter worth $30,000. Cherry Tree Wealth Management LLC acquired a new stake in shares of Rocket Lab in the second quarter valued at $32,000. Finally, Keating Financial Advisory Services Inc. acquired a new stake in shares of Rocket Lab in the second quarter valued at $39,000. Hedge funds and other institutional investors own 71.78% of the company’s stock.
About Rocket Lab
Rocket Lab USA, Inc is a space and launch company that provides launch services, spacecraft, satellite components and other space systems for commercial, civil and national-security customers. The company designs and manufactures many of its products in-house, supporting missions from initial spacecraft development through launch and on-orbit operations.
Rocket Lab’s primary launch vehicle is Electron, a small-lift rocket designed to place satellites into low Earth orbit. The company also operates the HASTE suborbital test platform for hypersonic and other advanced aerospace technologies and is developing Neutron, a larger reusable rocket intended to serve commercial and government missions.
See Also
- Five stocks we like better than Rocket Lab
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
- Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
- Arista Networks Plugs Into All-Time Highs
Receive News & Ratings for Rocket Lab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rocket Lab and related companies with MarketBeat.com's FREE daily email newsletter.
